Publicaciones

CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.

ω-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?

Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination.

Usefulness of a novel multiplex real-time PCR assay for the diagnosis of sexually-transmitted infections.

Use of H-Index and Other Bibliometric Indicators to Evaluate Research Productivity Outcome on Swine Diseases.

Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.

A Summary of the First HIV Microbiome Workshop 2015.

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy.